PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
02-Oct-2025 Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio Microbot Medical®
02-Oct-2025 Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson’s Disease and Movement Disorders® 2025 Lundbeck
02-Oct-2025 HemostOD secures CHF 4.3 million seed extension to advance through pre-IND development and commercial scale production HemostOD
02-Oct-2025 Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business Galapagos
02-Oct-2025 e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS e-therapeutic
02-Oct-2025 EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients EG 427
02-Oct-2025 Asabys Partners Integrates Aliath Bioventures Life Sciences Investment Platform in Strategic Move with AltamarCAM Asabys Partners
02-Oct-2025 Accumulus Synergy Appoints Khushboo Sharma as Chief Executive Officer Accumulus Synergy
01-Oct-2025 Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards Phastar
01-Oct-2025 eschbach Unites Manufacturing Teams With New Batch Tracking Solution for Shiftconnector® eschbach
01-Oct-2025 Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia Tiziana Life Sciences
01-Oct-2025 Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025 Kuros Biosciences
29-Sep-2025 Veranova Appoints Joe Torres-Ocasio as Senior Vice President, Chief Operating Officer Veranova
29-Sep-2025 Rezon Bio launches as a European biologics CDMO combining cost efficiency and digital innovation Rezon Bio
25-Sep-2025 GlobalData’s AI tool predicts pharmaceutical drug approvals with 85% success rate GlobalData
25-Sep-2025 Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress Tiziana
25-Sep-2025 Santhera Provides Update on Convertible Bond Issued on 23 September 2025 Santhera
25-Sep-2025 Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases Sentynl Therapeutics
24-Sep-2025 Major Shareholder Announcement Genmab
24-Sep-2025 Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System Miocrbot Medical®